Chemotherapy versus tyrosine kinase inhibitor in EGFR unselected population advanced non-small cell lung cancer still matter of debate?—An update incorporating the DELTA trial data...

Por Garassino, Marina C., Broggini, Massimo
Publicado no J Thorac Dis (2015)

Activity of Pan-Class I Isoform PI3K/mTOR Inhibitor PF-05212384 in Combination with Crizotinib in Ovarian Cancer Xenografts and PDX()

Por Iezzi, Alice, Caiola, Elisa, Broggini, Massimo
Publicado no Transl Oncol (2016)

p73 competes with p53 and attenuates its response in a human ovarian cancer cell line

Por Vikhanskaya, Faina, D’Incalci, Maurizio, Broggini, Massimo
Publicado em 2000

Evaluation of safety and efficacy of tivantinib in the treatment of inoperable or recurrent non-small-cell lung cancer

Por Broggini, Massimo, Garassino, Marina Chiara, Damia, Giovanna
Publicado em 2013

DNA damage induces transcriptional activation of p73 by removing C-EBPα repression on E2F1

Por Marabese, Mirko, Vikhanskaya, Faina, Rainelli, Cristina, Sakai, Toshiyuki, Broggini, Massimo
Publicado em 2003

Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2

Por Rastelli, Giulio, Anighoro, Andrew, Chripkova, Martina, Carrassa, Laura, Broggini, Massimo
Publicado em 2014

Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells

Por Brunelli, Laura, Caiola, Elisa, Marabese, Mirko, Broggini, Massimo, Pastorelli, Roberta
Publicado em 2014

Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo

Por Brunelli, Laura, Caiola, Elisa, Marabese, Mirko, Broggini, Massimo, Pastorelli, Roberta
Publicado no Sci Rep (2016)

Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53

Por Vikhanskaya, Faina, Lee, Ming Kei, Mazzoletti, Marco, Broggini, Massimo, Sabapathy, Kanaga
Publicado em 2007

Zebularine partially reverses GST methylation in prostate cancer cells and restores sensitivity to the DNA minor groove binder brostallicin

Por Sabatino, Maria Antonietta, Geroni, Cristina, Ganzinelli, Monica, Ceruti, Roberta, Broggini, Massimo
Publicado em 2013

Multi-Chemotherapeutic Schedules Containing the pan-FGFR Inhibitor ARQ 087 are Safe and Show Antitumor Activity in Different Xenograft Models()

Por Chilà, Rosaria, Hall G., Terence, Abbadessa, Giovanni, Broggini, Massimo, Damia, Giovanna
Publicado no Transl Oncol (2017)

Down-regulation of the Nucleotide Excision Repair gene <it>XPG </it>as a new mechanism of drug resistance in human and murine cancer cells

Por Geroni Cristina, Caiola Elisa, Ganzinelli Monica, Marabese Mirko, Sabatino Maria, Broggini Massimo
Publicado em 2010-09-01

KRas-LCS6 polymorphism does not impact on outcomes in ovarian cancer

Por Caiola, Elisa, Rulli, Eliana, Fruscio, Robert, Buda, Alessandro, Broggini, Massimo, Marabese, Mirko
Publicado em 2012

Combination of the c-Met Inhibitor Tivantinib and Zoledronic Acid Prevents Tumor Bone Engraftment and Inhibits Progression of Established Bone Metastases in a Breast Xenograft Mode...

Por Previdi, Sara, Scolari, Federica, Chilà, Rosaria, Ricci, Francesca, Abbadessa, Giovanni, Broggini, Massimo
Publicado em 2013

Different metabolic responses to PI3K inhibition in NSCLC cells harboring wild-type and G12C mutant KRAS

Por Caiola, Elisa, Brunelli, Laura, Marabese, Mirko, Broggini, Massimo, Lupi, Monica, Pastorelli, Roberta
Publicado no Oncotarget (2016)

Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743

Por Minuzzo, Mario, Marchini, Sergio, Broggini, Massimo, Faircloth, Glynn, D'Incalci, Maurizio, Mantovani, Roberto
Publicado em 2000

Down-regulation of the Nucleotide Excision Repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells

Por Sabatino, Maria Antonietta, Marabese, Mirko, Ganzinelli, Monica, Caiola, Elisa, Geroni, Cristina, Broggini, Massimo
Publicado em 2010

Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metasta...

Por Arrigoni, Chiara, De Luca, Paola, Gilardi, Mara, Previdi, Sara, Broggini, Massimo, Moretti, Matteo
Publicado em 2014

Cisplatinum and Taxol Induce Different Patterns of p53 Phosphorylation

Por Damia, Giovanna, Filiberti, Laura, Vikhanskaya, Faina, Carrassa, Laura, Taya, Yoichi, D'incalci, Maurizio, Broggini, Massimo
Publicado em 2001

Driving p53 Response to Bax Activation Greatly Enhances Sensitivity to Taxol by Inducing Massive Apoptosis

Por De Feudis, Paola, Vignati, Sara, Rossi, Cosmo, Mincioni, Tatiana, Giavazzi, Raffaella, D'Incalci, Maurizio, Broggini, Massimo
Publicado em 2000